全文获取类型
收费全文 | 272篇 |
免费 | 13篇 |
国内免费 | 11篇 |
专业分类
耳鼻咽喉 | 1篇 |
儿科学 | 6篇 |
妇产科学 | 2篇 |
基础医学 | 10篇 |
口腔科学 | 3篇 |
临床医学 | 50篇 |
内科学 | 64篇 |
皮肤病学 | 6篇 |
特种医学 | 94篇 |
外科学 | 18篇 |
综合类 | 6篇 |
预防医学 | 13篇 |
眼科学 | 3篇 |
药学 | 8篇 |
肿瘤学 | 12篇 |
出版年
2022年 | 2篇 |
2021年 | 3篇 |
2020年 | 1篇 |
2019年 | 6篇 |
2018年 | 5篇 |
2016年 | 4篇 |
2015年 | 5篇 |
2014年 | 4篇 |
2013年 | 6篇 |
2012年 | 4篇 |
2011年 | 2篇 |
2010年 | 9篇 |
2009年 | 7篇 |
2008年 | 6篇 |
2007年 | 9篇 |
2006年 | 6篇 |
2005年 | 9篇 |
2004年 | 9篇 |
2003年 | 4篇 |
2002年 | 6篇 |
2001年 | 6篇 |
2000年 | 7篇 |
1999年 | 7篇 |
1998年 | 8篇 |
1997年 | 11篇 |
1996年 | 9篇 |
1995年 | 8篇 |
1994年 | 11篇 |
1993年 | 13篇 |
1992年 | 2篇 |
1991年 | 3篇 |
1990年 | 6篇 |
1989年 | 8篇 |
1988年 | 8篇 |
1987年 | 11篇 |
1986年 | 11篇 |
1985年 | 8篇 |
1984年 | 1篇 |
1983年 | 3篇 |
1982年 | 2篇 |
1981年 | 5篇 |
1980年 | 5篇 |
1979年 | 5篇 |
1978年 | 7篇 |
1977年 | 10篇 |
1976年 | 4篇 |
1975年 | 2篇 |
1974年 | 5篇 |
1971年 | 1篇 |
1963年 | 1篇 |
排序方式: 共有296条查询结果,搜索用时 31 毫秒
71.
RS Jagavkar TP Shakespeare MJ Stevens 《Journal of Medical Imaging and Radiation Oncology》1998,42(2):157-158
The first documented case of endometrial adenosarcoma associated with chronic tamoxifen usage is reported. 相似文献
72.
1 引言
英国血液标准化委员会于1998年公布了第三版口服抗凝剂治疗指南,并于2006年修订.这些指南在安全性指征方面值得称道,但对开始口服抗凝剂治疗患者和已持续进行口服抗凝剂治疗的患者来说,安全性指征和危险性是相互伴随的.并非所有的安全性指征都要被医务工作者所采纳,而是为他们提供一种选择,可根据具体情况和需求选择最有用的指标.为了医疗服务的健康发展,这些安全性指征可以用来设立各种标准和规范,并进行相应的监督和审计. 相似文献
73.
Mutations and impaired function of LKB1 in familial and non-familial Peutz-Jeghers syndrome and a sporadic testicular cancer 总被引:8,自引:2,他引:6
Ylikorkala A; Avizienyte E; Tomlinson IP; Tiainen M; Roth S; Loukola A; Hemminki A; Johansson M; Sistonen P; Markie D; Neale K; Phillips R; Zauber P; Twama T; Sampson J; Jarvinen H; Makela TP; Aaltonen LA 《Human molecular genetics》1999,8(1):45-51
Germline mutations in LKB1 have been reported to underlie familial
Peutz-Jeghers syndrome (PJS) with intestinal hamartomatous polyps and an
elevated risk of various neoplasms. To investigate the prevalence of LKB1
germline mutations in PJS more generally, we studied samples from 33
unrelated PJS patients including eight non-familial sporadic patients, 20
familial patients and five patients with unknown family history. Nineteen
germline mutations were identified, 12 (60%) in familial and four (50%) in
sporadic cases. LKB1 mutations were not detected in 14 (42%) patients,
indicating that the existence of additional minor PJS loci cannot be
excluded. LKB1 is predicted to encode a serine/threonine kinase. To
demonstrate the putative Lkb1 kinase function and to study the consequences
of LKB1 mutations in PJS and sporadic tumors, we have analyzed the kinase
activity of wild-type and mutant Lkb1 proteins. Interestingly, while most
of the small deletions or missense mutations resulted in loss-of-function
alleles, one missense mutation (G163D) previously identified in a sporadic
testicular tumor demonstrated severely impaired but detectable kinase
activity.
相似文献
74.
75.
Supratentorial ependymoma: CT appearance 总被引:5,自引:0,他引:5
Armington WG; Osborn AG; Cubberley DA; Harnsberger HR; Boyer R; Naidich TP; Sherry RG 《Radiology》1985,157(2):367-372
The computed tomographic appearances of 22 biopsy-proved supratentorial ependymomas were analyzed. Supratentorial ependymomas were usually intraparenchymal, larger than 4 cm, and cystic. Contrast enhancement was moderate to intense, with homogeneous or ring-enhancement patterns commonly seen. Intratumoral calcification was present in one-third of the cases, while hydrocephalus and peritumoral edema were seen in 50%. Intratumoral hemorrhage was not a characteristic of the lesion. In contrast to cellular ependymomas, malignant ependymomas and ependymoblastomas demonstrate higher attenuation prior to administration of contrast material, more intense enhancement, lower frequency of calcification within the tumor, and less distinct margination. 相似文献
76.
77.
JI Tang TP Shakespeare JJ Lu YH Chan KM Lee LC Wong RK Mukherjee MF Back 《Journal of Medical Imaging and Radiation Oncology》2008,52(5):497-502
The palliative radiotherapeutic management of unresectable non‐small‐cell lung cancer is controversial, with various fractionation (Fx) schedules available. We aimed to determine patient’s choice of Fx schedule after involvement in a decision‐making process using a decision board. A decision board outlining the various advantages and disadvantages apparent in the Medical Research Council study of Fx schedules (17 Gy in two fractions vs 39 Gy in 13 fractions) was discussed with patients who met Medical Research Council eligibility criteria. Patients were then asked to indicate their preferred Fx schedules, reasons and their level of satisfaction with being involved in the decision‐making process. Radiation oncologists (RO) could prescribe radiotherapy schedules irrespective of patients’ preferences. Of 92 patients enrolled, 55% chose the longer schedule. English‐speaking patients were significantly more likely to choose the longer schedule (P = 0.02, 95% confidence interval: 1.2–7.6). Longer Fx was chosen because of longer survival (90%) and better local control (12%). Shorter Fx was chosen for shorter overall treatment duration (80%), cost (61%) and better symptom control (20%). In all, 56% of patients choosing the shorter schedule had their treatment altered by the treating RO, whereas only 4% of patients choosing longer Fx had their treatment altered (P < 0.001). Despite this, all (100%) patients were satisfied with being involved in the decision‐making process. The decision board was useful in aiding decision‐making, with both Fx schedules being acceptable to patients. Interestingly, despite the longer average survival associated with longer Fx, nearly half of the patients believed that this was not as important as a shorter duration of treatment and lower cost. Despite patients’ preferences, there were significant alterations of preferred schedules because of RO’s own biases. 相似文献
78.
This paper describes the clinical management of patients with malignant cells in their sputum and a normal chest roentgenogram and those with asymptomatic peripheral pulmonary masses. The source of malignant cells in the sputum of patients with no roentgenographic abnormalities can be localized by tantalum bronchography and fiberoptic bronchoscopy. Peripheral pulmonary masses can be diagnosed preoperatively by needle biopsy or transbronchial fiberoptic bronchoscopy with little morbidity and no mortality. These procedures are not necessary, however, if there is firm clinical and roentgenographic evidence of malignancy. Bronchogenic carcinomas presenting as asymptomatic circumscribed peripheral pulmonary masses have a 25% incidence of occult mediastinal lymph node metastases. In view of this relatively high incidence of metastasis, we think mediastinoscopy should routinely be performed prior to thoracotomy is asymptomatic patients with a peripheral pulmonary mass and no roentgenographic evidence of mediastinal widening. 相似文献
79.
80.